VestGen Advisors’s Arm ARM Stock Holding History

VestGen Advisors’s Portfolio ARM Stock Details ARM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.79M	Sell	19,141 -2,055	-10%	-$546K	0.2%	110
2026 Q1	$4.41M	Sell	21,196 -4,006	-16%	-$486K	0.12%	151
2025 Q4	$2.75M	Buy	25,202 +20,913	+488%	+$3.04M	0.12%	179
2025 Q3	$607K	Buy	+4,289	New	+$625K	0.02%	451

Other funds holding ARM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

VestGen Advisors's ARM Position: Q2 2026 in Review

VestGen Advisors reduced its Arm (ARM) stake by 9.7% in Q2 2026, selling an estimated $546K and leaving 19,141 shares worth $6.79M. The position accounts for 0.2% of the portfolio, ranked #110.

VestGen Advisors first reported a position in ARM in Q3 2025 and has held it in 4 quarters since. 957 funds tracked by Wall St. Rank hold ARM as of Q2 2026.

VestGen Advisors held 19,141 shares of Arm worth $6.79M as of Q2 2026.
VestGen Advisors sold 2,055 Arm shares in Q2 2026, an estimated $546K.
Arm made up 0.2% of VestGen Advisors's portfolio in Q2 2026, its #110 holding.
VestGen Advisors first reported a position in Arm in Q3 2025 and has held it in 4 quarters since.
957 funds tracked by Wall St. Rank held Arm as of Q2 2026.

Based on VestGen Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.